Skip to search formSkip to main contentSkip to account menu

CEP 8983

Known as: CEP-8983, CEP8983 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The cytotoxicity of PARP inhibitors olaparib, veliparib and CEP-8983 were investigated in two P-glycoprotein overexpressing drug… 
2016
2016
Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors may potentiate chemotherapy by hindering DNA damage repair pathways. CEP-9722… 
Highly Cited
2014
Highly Cited
2014
The cytotoxicity of PARP inhibitors olaparib, veliparib, and CEP-8983 were investigated in two P-glycoprotein (P-gp… 
2013
2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: Effective therapy for small cell lung… 
2012
2012
Chemical inhibitors of poly(ADP)ribose (PAR) polymerases (PARP) have generated raising expectations in cancer treatment, either… 
Highly Cited
2007
Highly Cited
2007
The effect of the potent and selective poly(ADP-ribose) (PAR) polymerase-1 [and PAR polymerase-2] inhibitor CEP-8983 on the…